Reticulum cell sarcoma, an oncologic model for a system of classifying the malignant lymphomas
| Autor: | D. Merten, H. Schmidt-Vollmer, K. Musshoff |
|---|---|
| Rok vydání: | 1971 |
| Předmět: |
Pathology
medicine.medical_specialty business.industry Lymphoma Non-Hodgkin Retrospective cohort study General Medicine Disease Prognosis medicine.disease Hodgkin Disease Lymphoma medicine.anatomical_structure Reticulum Cell Sarcoma Humans Medicine In patient Lymph Nodes Lymph Sarcoma business Lymph node Retrospective Studies |
| Zdroj: | European Journal of Cancer (1965). 7:451-457 |
| ISSN: | 0014-2964 |
| Popis: | In three quarters of those patients with lymphoreticular tumors (reticulum cell sarcoma and lymphoreticular sarcoma) the disease begins in lymph nodes and in one quarter of the cases in extranodular organs. If patients are suffering from primary lymph node involvement, the disease tends to be widespread. In patients with primary organ involvement the disease remains limited to local regions for a longer time and shows a greater tendency towards a continuous rather than a discontinuous spread. Patients with primary lymph node and organ involvement have almost the same prognosis when receiving the same treatment: In stages I and II the 5 year survival rates for primary lymph node involvement is 50% , for primary organ-involvement, 59% . The corresponding percentage rates of permanent cure are 48% and 45% . Under present therapy conditions, the prognosis of both forms in the advanced stages III and IV is very unfavourable. Comparative prognosis renders it possibly advisable to classify patients with primary lymph node and organ involvement together. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|